Biodesix

Biodesix

Health Care Providers & Services
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

$274.5M

Market Cap • 10/9/2026

2005

(21 years)

Founded

2020

(6 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

30

P/S

2,7

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,9

EPS

—

Market Cap

Market Cap

274,5M

EV

316,3M

EV/Revenue

3,1

EV/EBITDA

-21

EV/EBIT

-15,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-11,6%

Total Yield

-11,6%

Payout

0%

Retained Earnings

-512,8M

Profitability

Gross Margin

82,5%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

11,9%

Capex/Revenue

0,4%

Capex/D&A

7,4%

Capex/OCF

-2,1%

SBC/OCF

—

% PPE

28,7%

% Goodwill

15,8%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

6%

CAGR Op. Income 5Y

-3,8%

CAGR Net Income 5Y

-1,5%

CAGR EPS 5Y

-65,6%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,8

Quick Ratio

2,6

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium